Article Details
Retrieved on: 2021-07-23 10:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Arbutus Biopharma Corp (NASDAQ: ABUS) and Vaccitech PLC – ADR (NASDAQ: VACC) have entered into a partnership to carry out a clinical trial.
Article found on: techstockobserver.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here